Skip to Content
Merck

Skip To

SML1522

Doxofylline

≥98% (HPLC)

Synonym(s):

7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione, 7-(1,3-Dioxolan-2-ylmethyl)theophylline

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
50 mg
Please contact Customer Service for Availability
2 150,00 CZK

About This Item

Empirical Formula (Hill Notation):
C11H14N4O4
CAS Number:
Molecular Weight:
266.25
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥98% (HPLC)
Form:
powder

2 150,00 CZK


Please contact Customer Service for Availability

​
Request a Custom Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

H2O: 2 mg/mL, clear (warmed)

storage temp.

2-8°C

SMILES string

CN1C2=C(N(CC3OCCO3)C=N2)C(N(C)C1=O)=O

InChI

1S/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3

InChI key

HWXIGFIVGWUZAO-UHFFFAOYSA-N

General description

Doxofylline is a novel xanthine derivative comprising of dioxolone group.

Application

Doxofylline has been used as a phosphodiesterase (PDE) inhibitor to study its protective effects on lipopolysaccharides (LPS)-induced inflammatory response in human pulmonary bronchial epithelial cells. It has also been used to study its interaction with bovine serum albumin (BSA).

Biochem/physiol Actions

Doxofylline acts and as a non-selective phosphodiesterase (PDE) inhibitor and exhibits anti-inflammatory activity. It has the potential to treat chronic obstructive pulmonary disease (COPD).
Doxofylline (also known as doxophylline) has antitussive and bronchodilator effects. Doxofylline is used clinically in the treatment of asthma. Doxofylline has similar efficacy to theophylline, but unlike theophylline or other xanthines has little affinity for adenosine receptors and does not produce stimulant effects and has significantly fewer side effects.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
T1633237655D2800000
description

≥98% (HPLC)

description

anhydrous, ≥99%, powder

description

98%

description

European Pharmacopoeia (EP) Reference Standard

form

powder

form

powder

form

-

form

-

assay

≥98% (HPLC)

assay

≥99%

assay

98%

assay

-

Quality Level

100

Quality Level

200

Quality Level

100

Quality Level

-

storage temp.

2-8°C

storage temp.

-

storage temp.

2-8°C

storage temp.

2-8°C

solubility

H2O: 2 mg/mL, clear (warmed)

solubility

0.1 M NaOH: soluble, dilute HCl: soluble, ammonium hydroxide: soluble, NH4OH: 50 mg/ml, clear, colorless, H2O: slightly soluble 8.3 mg/ml, 0.1 M HCl: soluble, ethanol: moderately soluble, alcohol: 12.5 mg/ml, diethyl ether: slightly soluble, dilute nitric acid: soluble, aqueous base: soluble, chloroform: soluble 9.1 mg/ml

solubility

-

solubility

-

color

white to beige

color

white

color

-

color

-


Pictograms

Exclamation mark

Signal Word

Warning

Hazard Codes

Precautionary Statements

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library




Questions

  1. Is it a secondary reference standart?

    1 answer
    1. This product is not a secondary reference standard. It is intended for use in general laboratory research applications. Currently, this compound is not available as secondary reference standard.

      Helpful?

Reviews

No rating value

Active Filters